First-in-class predictive biomarkers to unlock antifibrotic therapy for breast cancer and beyond...
MeCo Diagnostics has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2024.
MeCo Diagnostics's investors include Team Ignite Ventures, GoAhead Ventures, Seattle Angel Conference.
MeCo Diagnostics is headquartered in San Diego, United States.
First-in-class predictive biomarkers to unlock antifibrotic therapy for breast cancer and beyond...
MeCo Diagnostics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MeCo Diagnostics — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/meco-diagnostics. Accessed August 15, 2026.
VCBacked. (2024). MeCo Diagnostics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/meco-diagnostics
{{cite web |title=MeCo Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/meco-diagnostics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated